Dr Reddy's Laboratories and Lupin are recalling products in the US market due to labelling and manufacturing errors, ...

Dr. Reddy's Laboratories Ltd. closed 17.44% short of its 52-week high of 1,420.20 rupees, which the company achieved on ...

That makes Germany one of the largest markets for medical cannabis products in Europe, with around 150,000 patients in the country taking them, according to Dr Reddy's, which also sees the Nimbus ...

Dr Reddy's Laboratories and Lupin are recalling products from the US market due to labelling and manufacturing issues. Dr ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Nomura recommends Buy for Dr. Reddy’s, Cipla, Lupin, Zydus amid pharma stock pressure. Check latest market trends!

Dr. Reddy's Laboratories Ltd. closed 16.71% below its 52-week high of 1,420.20 rupees, which the company reached on August ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.